To mitigate this limitation, integrating gene expression‐based ranking with complementary approaches such as functional assays, chromatin accessibility profiling (e.g., ATAC‐seq), and TF activity inference methods (e.g., motif enrichment or TF target analysis) could provide a more comprehensive view of TF dynamics in prostate cancer progression. This evidence concerns the gene TF and prostate carcinoma.